Ciprian Tomuleasa

Iuliu Hațieganu University of Medicine and Pharmacy — Romania

Medicine · Health Sciences

35h-index4.8kcitations303works5.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(48), Lymphoma Diagnosis and Treatment(34), Myeloproliferative Neoplasms: Diagnosis and Treatment(31), Chronic Lymphocytic Leukemia Research(25), Chronic Myeloid Leukemia Treatments(24)

Publications302 total

The Endothelial Puzzle: Uncovering Risk Factors for TA-TMA after Allogeneic Transplantation
Transplantation and Cellular Therapy·2026
Paediatric Hospitalised Immune Thrombocytopenia in Real-Life Recent Viral Infection Outbreaks: A Retrospective Study
Life·2025Open Access
Performance of radiomics features in patients with peripheral T-cell lymphoma: Data from international prospective T-cell project 2.0
Blood·2025Open Access
From efficacy to experience: 52-week patient-reported outcomes with Mim8 in adolescents and adults with hemophilia A with or without inhibitors (FRONTIER2)
Blood·2025Open Access
CARing about autoimmune disorders. Use of chimeric antigen receptor engineered T-cells in autoimmune diseases
Blood Reviews·2025Open Access
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: AN INTERNATIONAL REGISTRY STUDY (THE PLATO STUDY)
Hematology Transfusion and Cell Therapy·2025Open Access
Shear Wave Elastography for Distinguishing Cervical Lymph Node Malignancy: A Prospective, Observational Study
Biomedicines·2025· 1 citedOpen Access
Challenges in the preclinical design and assessment of CAR-T cells
Frontiers in Immunology·2025· 5 citedOpen Access
875 | JOINT ANALYSIS OF 1695 CASES OF MALIGNANT LYMPHOMA FROM THE UKRANIAN AND CLUJ NAPOCA LYMPHOMA REGISTRIES
Hematological Oncology·2025Open Access
14 | PERFORMANCE OF BASELINE AND END‐OF‐TREATMENT FDG‐PET RADIOMICS IN PATIENTS WITH PERIPHERAL T‐CELL LYMPHOMA: DATA FROM INTERNATIONAL PROSPECTIVE T‐CELL PROJECT 2.0
Hematological Oncology·2025Open Access
386 | NUMBER OF EXTRANODAL SITES IN PTCL AS PROGNOSTIC MARKER IN REAL‐WORLD SETTING. AN ANALYSIS OF 645 CASES ENROLLED IN THE T‐CELL PROJECT 2
Hematological Oncology·2025Open Access
894 | REAL LIFE EXPERIENCE WITH SILTUXIMAB IN CASTLEMAN DISEASE
Hematological Oncology·2025Open Access
883 | SILTUXIMAB IN IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE: REAL‐WORLD EXPERIENCE FROM ROMANIA AND GREECE
Hematological Oncology·2025Open Access
402 | RELAPSED/REFRACTORY PERIPHERAL T‐CELL LYMPHOMAS: REPORT ON 641 PATIENTS FROM THE T‐CELL PROJECT 2.0
Hematological Oncology·2025Open Access
A mathematical model of clonal hematopoiesis explaining phase transitions in chronic myeloid leukemia
Mathematical Medicine and Biology A Journal of the IMA·2025· 1 citedOpen Access
Insights into Pediatric GATA2-Related MDS: Unveiling Challenges in Clinical Practice
Biomedicines·2025· 1 citedOpen Access
P-07.04 Mantle Cell Lymphoma in sight: development of anti-ROR1 CAR T-cell therapy, andenhancement of its safety profile by iCasp9 suicidal gene expression
Poster presentations·2025Open Access
EPYSQLI (SB12; Biosimilar to Reference Eculizumab) in Asian and Non‐Asian Patients With Paroxysmal Nocturnal Hemoglobinuria: Subgroup Analysis of a Global Phase III Randomized Controlled Trial
eJHaem·2025Open Access
GATA2-related myeloid malignancies
2025Open Access
Mim8 Prophylaxis Beyond Bleeding: Investigating Multifaceted, Patient-reported Outcomes for Hemophilia A in the FRONTIER2 Study
Hämostaseologie·2025
page 1 of 16Next →

Frequent Co-authors

Ioana Berindan‐Neagoe(16), Bobe Petrushev(16), Delia Dima(12), Olga Şoriţău(9), Ancuța Jurj(8), Alexandru Irimie(8), Sergiu Paşca(8), Mihaela Aldea(7), Gabriel Kacsó(7), Vlad Moisoiu(7), Alina Tănase(7), Laura Pop(6), Cristian Berce(6), Sergiu Șușman(5), Horia Bumbea(5), Patric Teodorescu(5), Cătălin Constantinescu(5), Timea Nagy-Simon(5), Sanda Boca(5), Simion Aştilean(5)